Elanix Biotechnologies AG

Informe acción DB:ELN

Capitalización de mercado: €428.3k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Salud financiera de hoja de balance de Elanix Biotechnologies

Salud financiera controles de criterios 0/6

Insufficient data to determine the health of Elanix Biotechnologies

Información clave

n/a

Ratio deuda-patrimonio

n/a

Deuda

Ratio de cobertura de interesesn/a
Efectivon/a
Patrimonion/a
Total pasivon/a
Activos totalesn/a

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Análisis de la situación financiera

Pasivos a corto plazo: Insufficient data to determine if ELN's short term assets cover its short term liabilities.

Pasivo a largo plazo: Insufficient data to determine if ELN's short term assets cover its long term liabilities.


Historial y análisis de deuda-patrimonio

Nivel de deuda: Insufficient data to calculate ELN's net debt to equity ratio to determine if it is satisfactory.

Reducción de la deuda: Insufficient data to determine if ELN's debt to equity ratio has reduced over the past 5 years.

Cobertura de la deuda: Insufficient data to determine if ELN's debt is well covered by operating cash flow.

Cobertura de intereses: Insufficient data to determine if ELN's interest payments on its debt are well covered by EBIT.


Hoja de balance


Descubre empresas con salud financiera

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target